Filing Details

Accession Number:
0001562180-19-002466
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-01 16:05:38
Reporting Period:
2019-04-29
Accepted Time:
2019-05-01 16:05:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1271214 Intersect Ent Inc. XENT Surgical & Medical Instruments & Apparatus (3841) 200280837
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1614499 P Susan Stimson C/O Intersect Ent, Inc.
1555 Adams Drive
Menlo Park CA 94025
Chief Strategy Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-04-29 12,500 $21.06 36,530 No 4 M Direct
Common Stock Disposition 2019-04-29 12,500 $31.06 24,030 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2019-04-29 12,500 $0.00 12,500 $21.06
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2025-01-20 No 4 M Direct
Footnotes
  1. Since the date of the reporting person's last ownership report, she transferred 19,085 shares of Intersect ENT, Inc. common stock and employee stock options to purchase 47,750 shares of Intersect ENT, Inc. common stock pursuant to a domestic relations order. The reporting person no longer reports such transferred securities as beneficially owned by her.
  2. Includes 10,017 Restricted Stock Units.
  3. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 6, 2019.
  4. The vesting commencement date of the option is January 1st, 2015. 1/8th of the shares subject to the option vested on July 1st, 2015 and 1/48th of the remaining shares subject to the option will vest monthly thereafter over 42 months.